Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

SELUMETINIB vs SENSIPAR: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

SELUMETINIB vs SENSIPAR: Safety Overview

Metric SELUMETINIB SENSIPAR
Total FAERS Reports 1,172 577
Deaths Reported 81 82
Death Rate 6.9% 14.2%
Hospitalizations 211 52
Average Patient Age 25.6 yrs 62.8 yrs
% Female Patients 51.6% N/A
FDA Approval Date Apr 10, 2020 N/A
Manufacturer AstraZeneca Pharmaceuticals LP N/A
Route ORAL N/A
Marketing Status Prescription N/A